Personensuche
X
?
1
Additional file 1 of PCSK9 inhibitor recaticimab for hyperc..:
Mingtong Xu (673031) ; Xiaoxue Zhu (562629) ; Junyan Wu (4717161)...
https://figshare.com/articles/journal_contribution/Additional_file_1_of_PCSK9_inhibitor_recaticimab_for_hypercholesterolemia_on_stable_statin_dose_a_randomized_double-blind_placebo-controlled_phase_1b_2_study/18585562. , 2022
https://figshare.com/articles/journal_contribution/Additional_file_1_of_PCSK9_inhibitor_recaticimab_for_hypercholesterolemia_on_stable_statin_dose_a_randomized_double-blind_placebo-controlled_phase_1b_2_study/18585562. , 2022
?
2
The effect of a single escalating dose of long-acting recom..:
Hong Zhang (25820) ; Yanyan Fan (1464562) ; Lei Gao (6566)...
https://figshare.com/articles/journal_contribution/The_effect_of_a_single_escalating_dose_of_long-acting_recombinant_human_follicle-stimulating_hormone_Fc_fusion_protein_KN015_on_healthy_pituitary-suppressed_women_first-in-human_and_randomized_study_on_its_pharmacokinetics_pharmacodynamics_/21757371. , 2022
https://figshare.com/articles/journal_contribution/The_effect_of_a_single_escalating_dose_of_long-acting_recombinant_human_follicle-stimulating_hormone_Fc_fusion_protein_KN015_on_healthy_pituitary-suppressed_women_first-in-human_and_randomized_study_on_its_pharmacokinetics_pharmacodynamics_/21757371. , 2022
?
3
Table1_A Biosimilarity Study Between QX001S and Ustekinumab..:
Lei Gao (6566) ; Qingmei Li (301661) ; Hong Zhang (25820)...
https://figshare.com/articles/dataset/Table1_A_Biosimilarity_Study_Between_QX001S_and_Ustekinumab_in_Healthy_Chinese_Male_Subjects_doc/14609331. , 2021
https://figshare.com/articles/dataset/Table1_A_Biosimilarity_Study_Between_QX001S_and_Ustekinumab_in_Healthy_Chinese_Male_Subjects_doc/14609331. , 2021
?
4
image1_Phase I Trial to Evaluate the Tolerance, Pharmacokin..:
Jingrui Liu (1694983) ; Hong Zhang (25820) ; Xiaoxue Zhu (562629)...
https://figshare.com/articles/figure/image1_Phase_I_Trial_to_Evaluate_the_Tolerance_Pharmacokinetics_and_Efficacy_of_the_Broad-Spectrum_ErbB_Family_Inhibitor_Larotinib_Mesylate_in_Patients_With_Advanced_Solid_Tumors_tif/14051792. , 2021
https://figshare.com/articles/figure/image1_Phase_I_Trial_to_Evaluate_the_Tolerance_Pharmacokinetics_and_Efficacy_of_the_Broad-Spectrum_ErbB_Family_Inhibitor_Larotinib_Mesylate_in_Patients_With_Advanced_Solid_Tumors_tif/14051792. , 2021
?
5
Image2_First-in-Human, Double-Blind, Randomized, Placebo-Co..:
Jingrui Liu (1694983) ; Xiaoxue Zhu (562629) ; Hong Zhang (25820)...
https://figshare.com/articles/figure/Image2_First-in-Human_Double-Blind_Randomized_Placebo-Controlled_Trial_of_TQ-F3083_a_New_Dipeptidyl_Peptidase-4_Inhibitor_in_Healthy_Chinese_Adults_TIF/15033516. , 2021
https://figshare.com/articles/figure/Image2_First-in-Human_Double-Blind_Randomized_Placebo-Controlled_Trial_of_TQ-F3083_a_New_Dipeptidyl_Peptidase-4_Inhibitor_in_Healthy_Chinese_Adults_TIF/15033516. , 2021
?
6
A randomized phase-I pharmacokinetic trial comparing the po..:
Hong Zhang (25820) ; Xiaojiao Li (193668) ; Jingrui Liu (1694983)...
https://figshare.com/articles/journal_contribution/A_randomized_phase-I_pharmacokinetic_trial_comparing_the_potential_biosimilar_tocilizumab_QX003S_with_the_reference_product_Actemra_sup_sup_in_Chinese_healthy_subjects/14114296. , 2021
https://figshare.com/articles/journal_contribution/A_randomized_phase-I_pharmacokinetic_trial_comparing_the_potential_biosimilar_tocilizumab_QX003S_with_the_reference_product_Actemra_sup_sup_in_Chinese_healthy_subjects/14114296. , 2021
?
7
Image3_First-in-Human, Double-Blind, Randomized, Placebo-Co..:
Jingrui Liu (1694983) ; Xiaoxue Zhu (562629) ; Hong Zhang (25820)...
https://figshare.com/articles/figure/Image3_First-in-Human_Double-Blind_Randomized_Placebo-Controlled_Trial_of_TQ-F3083_a_New_Dipeptidyl_Peptidase-4_Inhibitor_in_Healthy_Chinese_Adults_TIF/15033519. , 2021
https://figshare.com/articles/figure/Image3_First-in-Human_Double-Blind_Randomized_Placebo-Controlled_Trial_of_TQ-F3083_a_New_Dipeptidyl_Peptidase-4_Inhibitor_in_Healthy_Chinese_Adults_TIF/15033519. , 2021
?
8
datasheet1_A Phase I, Randomized, Double-Blind, Placebo-Con..:
Jingrui Liu (1694983) ; Binhua Lv (1840729) ; Hewen Yin (9765389)...
https://figshare.com/articles/dataset/datasheet1_A_Phase_I_Randomized_Double-Blind_Placebo-Controlled_Single_Ascending_Dose_Multiple_Ascending_Dose_and_Food_Effect_Study_to_Evaluate_the_Tolerance_Pharmacokinetics_of_Jaktinib_a_New_Selective_Janus_Kinase_Inhibitor_in_Healthy_Chi/13603520. , 2021
https://figshare.com/articles/dataset/datasheet1_A_Phase_I_Randomized_Double-Blind_Placebo-Controlled_Single_Ascending_Dose_Multiple_Ascending_Dose_and_Food_Effect_Study_to_Evaluate_the_Tolerance_Pharmacokinetics_of_Jaktinib_a_New_Selective_Janus_Kinase_Inhibitor_in_Healthy_Chi/13603520. , 2021
?
9
Image1_First-in-Human, Double-Blind, Randomized, Placebo-Co..:
Jingrui Liu (1694983) ; Xiaoxue Zhu (562629) ; Hong Zhang (25820)...
https://figshare.com/articles/figure/Image1_First-in-Human_Double-Blind_Randomized_Placebo-Controlled_Trial_of_TQ-F3083_a_New_Dipeptidyl_Peptidase-4_Inhibitor_in_Healthy_Chinese_Adults_TIF/15033513. , 2021
https://figshare.com/articles/figure/Image1_First-in-Human_Double-Blind_Randomized_Placebo-Controlled_Trial_of_TQ-F3083_a_New_Dipeptidyl_Peptidase-4_Inhibitor_in_Healthy_Chinese_Adults_TIF/15033513. , 2021